Karin Seifert

3.2k total citations
70 papers, 2.5k citations indexed

About

Karin Seifert is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, Karin Seifert has authored 70 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 20 papers in Epidemiology and 16 papers in Organic Chemistry. Recurrent topics in Karin Seifert's work include Research on Leishmaniasis Studies (28 papers), Trypanosoma species research and implications (18 papers) and Synthesis and Biological Evaluation (10 papers). Karin Seifert is often cited by papers focused on Research on Leishmaniasis Studies (28 papers), Trypanosoma species research and implications (18 papers) and Synthesis and Biological Evaluation (10 papers). Karin Seifert collaborates with scholars based in United Kingdom, Germany and Austria. Karin Seifert's co-authors include Simon L. Croft, Vanessa Yardley, Michael Duchêne, Santiago Castanys, F. Javier Pérez‐Victoria, Francisco Gamarro, S. L. Croft, María P. Sánchez‐Cañete, Patricia Escobar and Stefan Schütz and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and New Phytologist.

In The Last Decade

Karin Seifert

66 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Seifert United Kingdom 25 1.4k 818 505 458 330 70 2.5k
Robert H. Barker United States 27 667 0.5× 436 0.5× 250 0.5× 409 0.9× 71 0.2× 75 2.0k
S. W. Homans United Kingdom 24 468 0.3× 614 0.8× 536 1.1× 961 2.1× 162 0.5× 36 1.9k
Manabu Igarashi Japan 26 250 0.2× 995 1.2× 65 0.1× 396 0.9× 276 0.8× 92 2.3k
David W. Boykin United States 39 863 0.6× 1.0k 1.3× 1.8k 3.5× 2.3k 5.0× 78 0.2× 133 4.5k
Atanu Basu India 26 469 0.3× 364 0.4× 228 0.5× 1.2k 2.5× 348 1.1× 61 3.5k
M.C. Vaney France 24 1.6k 1.2× 711 0.9× 35 0.1× 802 1.8× 117 0.4× 36 3.1k
Richard G. Nelson United States 28 498 0.4× 844 1.0× 104 0.2× 1.2k 2.5× 202 0.6× 44 2.7k
Arvind Kumar United States 34 555 0.4× 729 0.9× 1.6k 3.1× 1.8k 4.0× 98 0.3× 138 3.8k
David J. Filman United States 40 203 0.1× 1.3k 1.6× 269 0.5× 3.4k 7.4× 788 2.4× 73 7.0k
Shobhona Sharma India 30 934 0.7× 224 0.3× 63 0.1× 804 1.8× 78 0.2× 88 2.2k

Countries citing papers authored by Karin Seifert

Since Specialization
Citations

This map shows the geographic impact of Karin Seifert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Seifert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Seifert more than expected).

Fields of papers citing papers by Karin Seifert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Seifert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Seifert. The network helps show where Karin Seifert may publish in the future.

Co-authorship network of co-authors of Karin Seifert

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Seifert. A scholar is included among the top collaborators of Karin Seifert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Seifert. Karin Seifert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goedecke, Thomas, Nathalie Gault, Karin Seifert, et al.. (2024). Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations. Pharmacoepidemiology and Drug Safety. 33(8). e5874–e5874. 1 indexed citations
2.
3.
Zelmer, Andrea, et al.. (2019). RUTI Vaccination Enhances Inhibition of Mycobacterial Growth ex vivo and Induces a Shift of Monocyte Phenotype in Mice. Frontiers in Immunology. 10. 894–894. 24 indexed citations
4.
Zelmer, Andrea, Lisa Stockdale, Utkarsh Ojha, et al.. (2019). Historical BCG vaccination combined with drug treatment enhances inhibition of mycobacterial growth ex vivo in human peripheral blood cells. Scientific Reports. 9(1). 4842–4842. 11 indexed citations
5.
Salguero, Francisco J., et al.. (2018). Histopathological and immunohistochemical characterisation of hepatic granulomas in Leishmania donovani-infected BALB/c mice: a time-course study. Parasites & Vectors. 11(1). 73–73. 29 indexed citations
6.
Koniordou, Markela, Stephen Patterson, Susan Wyllie, & Karin Seifert. (2017). Snapshot Profiling of the Antileishmanial Potency of Lead Compounds and Drug Candidates against Intracellular Leishmania donovani Amastigotes, with a Focus on Human-Derived Host Cells. Antimicrobial Agents and Chemotherapy. 61(3). 14 indexed citations
7.
Seifert, Karin, et al.. (2015). Preclinical safety and tolerability of a repeatedly administered human leishmaniasis DNA vaccine. Gene Therapy. 22(8). 628–635. 18 indexed citations
8.
Seifert, Karin, et al.. (2013). An Essential Type I Nitroreductase from Leishmania major Can Be Used to Activate Leishmanicidal Prodrugs. Journal of Biological Chemistry. 288(40). 28466–28476. 26 indexed citations
9.
Seifert, Karin, Patricia Escobar, & S. L. Croft. (2010). In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent. Journal of Antimicrobial Chemotherapy. 65(3). 508–511. 105 indexed citations
10.
Seifert, Karin, et al.. (2008). N-(2-hydroxypropyl)methacrylamide–amphotericin B (HPMA–AmB) copolymer conjugates as antileishmanial agents. International Journal of Antimicrobial Agents. 33(5). 441–448. 53 indexed citations
11.
Pérez‐Victoria, F. Javier, María P. Sánchez‐Cañete, Karin Seifert, et al.. (2006). Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resistance Updates. 9(1-2). 26–39. 147 indexed citations
12.
Dötterl, Stefan, et al.. (2005). Nursery pollination by a moth in Silene latifolia: the role of odours in eliciting antennal and behavioural responses. New Phytologist. 169(4). 707–718. 147 indexed citations
13.
Seifert, Karin, et al.. (2003). Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine). International Journal of Antimicrobial Agents. 22(4). 380–387. 137 indexed citations
14.
Seifert, Karin, Michael Duchêne, Walther H. Wernsdorfer, et al.. (2000). A New Approach for Chemotherapy Against Entamoeba histolytica. Archives of Medical Research. 31(4). S6–S7. 3 indexed citations
15.
Seifert, Karin, et al.. (1994). A Novel Anthranilic Acid Derivative fromIsatis tinctoria. Planta Medica. 60(6). 578–579. 7 indexed citations
16.
Seifert, Karin, et al.. (1994). Flavonoids fromAchillea micrantha. Planta Medica. 60(6). 600–600. 4 indexed citations
17.
Lübec, Gert, et al.. (1985). Structural changes of hair after incorporation of the proline analogue L-azetidine-2-carboxylic acid. A model of hair disease by alteration of primary structure.. PubMed. 97(9). 401–3. 3 indexed citations
18.
Seifert, Karin, et al.. (1978). ブロモピルビン酸エチルエステルとチオセミカルバジドの反応と4‐カルボエトキシまたは4‐カルボキシ置換チアゾリル‐(2)‐ヒドラジン誘導体の合成. Pharmazie. 33(5). 259–263. 9 indexed citations
19.
Seifert, Karin, H. Budzikiewicz, & K. Schreiber. (1976). [Triterpenes of Cucurbita lundelliana].. PubMed. 31(11). 816–7. 1 indexed citations
20.
Seifert, Karin, et al.. (1968). Light-induced redox reaction between chlorophyll and quinone in iso-butanol.. PubMed. 55(5). 222–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert H. Barker Breakdown of academic impact, for papers by S. W. Homans Breakdown of academic impact, for papers by Manabu Igarashi Breakdown of academic impact, for papers by David W. Boykin Breakdown of academic impact, for papers by Atanu Basu Breakdown of academic impact, for papers by M.C. Vaney Breakdown of academic impact, for papers by Richard G. Nelson Breakdown of academic impact, for papers by Arvind Kumar Breakdown of academic impact, for papers by David J. Filman Breakdown of academic impact, for papers by Shobhona Sharma
Rankless by CCL
2026